Sun Nov 22, 2009
UCLA Health System Research and Education: David Geffen School of Medicine at UCLAPatient Care: UCLA Health System
UCLA Center for Esophageal Disorders
Home
About Us
Our Expert Team
Preparing for your visit
Preparing for Surgery
Conditions and Treatments
Patient Stories
Spotlight
Clinical Trials and Research
Contact Us
Medical Terms
Giving / Donations
Esophageal News



 

Clinical Trials and Research

Research - Center For Esophageal Disorders at UCLAA Phase II Study of Erlotinib and modified FOLFOX-6
(5-Fluorouracil, Leucovorin and Oxaliplatin) in Previously Untreated Patients with Unresectable or Metastatic Adenocarcinoma of Esophagus and Gastric Cardia.

  • IRB# 07-12-010

  • For more information contact:



    • Zev Wainberg, MD
    • or Vivian Nguyen
    • 310-794-5463